SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-031599
Filing Date
2021-06-03
Accepted
2021-06-03 16:58:44
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 vtvt-s3.htm S-3 327619
2 EX-5.1 vtvt-ex51_81.htm EX-5.1 14222
3 EX-23.1 vtvt-ex231_28.htm EX-23.1 2738
4 GRAPHIC goxfd5nprrgx000001.jpg GRAPHIC 22172
5 GRAPHIC goxfd5nprrgx000002.jpg GRAPHIC 22172
  Complete submission text file 0001564590-21-031599.txt   407039
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256755 | Film No.: 21993287
SIC: 2834 Pharmaceutical Preparations